Aptevo Therapeutics (APVO) Payables (2015 - 2026)
Aptevo Therapeutics' Payables came in at $1.16 million for Q2 2026, down 60.0% from $2.9 million a year earlier but up 30.6% from the prior quarter.
Analysis
Aptevo Therapeutics (APVO) Payables (2015 - 2026) Analysis & Trends
At the end of FY2025, Aptevo Therapeutics' Payables was $877,000, down 29.4% from FY2024.
- Payables carries a five-year compound annual growth rate of -30.9% (FY2020 to FY2025).
- Going back by year, Payables was $1.24 million in FY2024 (-68.8%), $3.98 million in FY2023 (+13.9%), $3.5 million in FY2022 (+1.1%) and $3.46 million in FY2021 (-38.0%).
- The five-year range for quarterly Payables is $877,000 (Q4 2025) to $4.87 million (Q2 2023).
- Year-over-year, Payables has declined for five consecutive quarters, with an average decline of 38.0% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q2 2023 (growth of 49.1%), and the weakest in Q1 2026 (a decline of 76.5%).
- Business Quant data shows APVO's Payables at $890,000 (Q1 2026), $877,000 (Q4 2025) and $2.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Aptevo Therapeutics | 2.71 Mn | -64.29 Mn | - | 1.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 890,000.00 |
| Dec 31, 2025 | 877,000.00 |
| Sep 30, 2025 | 2.22 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.74 Mn |
| Mar 31, 2024 | 3.72 Mn |
| Dec 31, 2023 | 3.98 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 4.87 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Sep 30, 2022 | 3.24 Mn |
| Jun 30, 2022 | 3.27 Mn |
| Mar 31, 2022 | 3.91 Mn |
| Dec 31, 2021 | 3.46 Mn |
| Sep 30, 2021 | 3.69 Mn |
API Access
Aptevo Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=APVO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();